News

Interferon-free treatment combo looks promising for HCV GT2, GT3 infection

Posted on: 18/11/2015 - 13:39

SAN FRANCISCO – The investigational combination of ombitasvir, paritaprevir, and ritonavir when given with sofosbuvir (OBV/PTV/r + SOF) for 12 weeks appears to be a highly effective treatment option...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: 12-week HCV retreatment effective if short course fails

Posted on: 18/11/2015 - 13:22

SAN FRANCISCO – Can patients who fail short-course treatment for hepatitis C and show high levels of resistance to an antiviral drug still respond to standard 12-week therapy? “There were initially...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir/R yields benefits in compassionate use HCV program

Posted on: 17/11/2015 - 23:23

SAN FRANCISCO – The direct-acting antiviral sofosbuvir plus ribavirin (SOF/R) improved liver function in patients with hepatitis C virus infection who were awaiting liver transplant and it produced a...

Field of Interest: Gastroentero...

Type: News Item

Multibiomarker blood test could aid treatment decisions in RA

Posted on: 17/11/2015 - 23:07

SAN FRANCISCO – Vectra DA, a multibiomarker blood test, can predict response to therapy for patients with rheumatoid arthritis, and it can also identify patients who can safely taper and...

Field of Interest: Rheumatology

Type: News Item

CTAD: New aducanumab subanalysis bolsters phase III trials in very mild Alzheimer’s

Posted on: 17/11/2015 - 22:44

BARCELONA – A new look at aducanumab’s phase I study data has reinforced the developer’s confidence that its newly launched phase III trials are targeting the right group: patients with very early...

Field of Interest: Geriatrics

Type: News Item

CTAD: Sigma-1 receptor agonist passes muster in small Alzheimer’s trial

Posted on: 17/11/2015 - 21:58

BARCELONA – A novel small molecule that may help clear misfolded proteins imparted some significant cognitive benefits to Alzheimer’s patients after 5 weeks, even with a mid-study washout period in...

Field of Interest: Geriatrics

Type: News Item

VIDEO: Longer HCV therapy worked even after short-term failures

Posted on: 17/11/2015 - 21:40

SAN FRANCISCO – Patients with hepatitis C who fail short-course antiviral treatment may still be able to achieve a cure using longer-duration therapies plus ribavirin, a small study has...

Field of Interest: Gastroentero...

Type: News Item

Multitargeted drug combination promising when new HCV antivirals fail

Posted on: 17/11/2015 - 21:22

SAN FRANCISCO – A five-drug regimen of direct-acting antiviral agents with diverse targets appears to be highly effective as a retreatment in patients infected with the hepatitis C virus patients who...

Field of Interest: Gastroentero...

Type: News Item

Regimen effective in genotype 3 HCV despite advanced cirrhosis

Posted on: 17/11/2015 - 19:45

SAN FRANCISCO – Sustained virologic response in patients with genotype 3 hepatitis C virus infection and advanced fibrosis or cirrhosis was achieved in 88% of those treated with a daclatasvir-based...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Antigen test could simplify HCV screening

Posted on: 17/11/2015 - 19:34

SAN FRANCISCO – Hepatitis C testing can be time consuming, expensive, and not widely available, but a new test focused on hepatitis C antigen detection might simplify the process and reduce its...

Field of Interest: Geriatrics

Type: News Item

« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters